Two Sigma Securities, LLC Global Blood Therapeutics, Inc. Put Options Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $204,428 - $427,280	-4,900 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $223,930 - $401,114	4,900 New	4,900 $390,000
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $725,600 - $926,560	-16,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $583,860 - $702,519	11,100 Added 226.53%	16,000 $842,000
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $195,951 - $262,051	4,900 New	4,900 $259,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.